NCT05636865

Brief Summary

placenta accreta spectrum incidence and outcome

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 30, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2022

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

November 13, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 5, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2023

Completed
Last Updated

December 5, 2022

Status Verified

November 1, 2022

Enrollment Period

3 months

First QC Date

November 13, 2022

Last Update Submit

November 24, 2022

Conditions

Placenta Accreta

Keywords

PAS

Outcome Measures

Primary Outcomes (1)

  • number of diagnosed pregnant women with placenta accreta spectrum

    pregnant women with gestitional age above 18 week , with confirmed diagnosis with PAS with U/S

    in last 6 years

Secondary Outcomes (1)

  • incidence of hystrectomy

    in last 6 years

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

pregnant woman above 28 weeks

You may qualify if:

  • gestational age above 28 weeks

You may not qualify if:

  • age less than 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasr Alainy , Cairo University

Cairo, 002, Egypt

Location

MeSH Terms

Conditions

Placenta Accreta

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Study Officials

  • rihab hagag, resident

    kasr alainy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor , principle investigator

Study Record Dates

First Submitted

November 13, 2022

First Posted

December 5, 2022

Study Start

July 30, 2022

Primary Completion

November 10, 2022

Study Completion

March 30, 2023

Last Updated

December 5, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

incidence of PAS

Locations

EG(1)